RIPTACs: Reshaping Precision Oncology Beyond PROTACs
Introduction: Targeted induced-proximity therapeutics have transformed drug discovery. PROTACs induce ubiquitin-mediated degradation of disease proteins, whereas RIPTACs selectively eliminate biomarker-positive cells by recruiting essential proteins to disease-specific proteins. Mechanistic Differences PROTACs vs RIPTACs: Figure-1: Mechanism of action- PROTACs vs RIPTACs Detailed Comparison- PROTACs vs RIPTACs: Parameter PROTACs RIPTACs Full Form Proteolysis Targeting Chimera Regulated Induced […]